HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started
International Journal of Immunogenetics · 2021-04 · 48 (2) · 193-200
DOI: 10.1111/iji.12517 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Immunogenetics, online erschienen am 28.10.2020. Verfasst von Milena Ivanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, University Hospital Alexandrovska, Medical University Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NSF (Bulgaria).
Abstract (Originalsprache)
The implementation of the immune checkpoint blockade as a therapeutic option in contemporary oncology is one of the significant immunological achievements in the last century. Constantly accumulating evidence suggests that the response to immune checkpoint inhibitors (ICIs) is not universal. Therefore, it is critical to identify determinants for response, resistance and adverse effects of immune checkpoint therapy that could be developed as prognostic and predictive markers. Recent large scale analyses of cancer genome data revealed the key role of HLA class I and class II molecules in cancer immunoediting, and it appears that HLA diversity can predict response to ICIs. In the present review, we summarize the emerging data on the role of HLA germline variations as a marker for response to ICIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, University Hospital Alexandrovska, Medical University Sofia, Sofia, Bulgaria.
- Department of Genetics, St. Kliment Ohridski University, Sofia, Bulgaria.
ORCID-Profile: Milena Ivanova, Velizar Shivarov
Förderung
- NSF (Bulgaria)
Zitieren
APA
Ivanova, M., & Shivarov, V. (2021). HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started. International Journal of Immunogenetics, 48(2), 193-200. https://doi.org/10.1111/iji.12517
Vancouver
Ivanova M, Shivarov V. HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started. International Journal of Immunogenetics. 2021;48(2):193-200. doi:10.1111/iji.12517
BibTeX
@article{Ivanova2021,
author = {Ivanova, Milena and Shivarov, Velizar},
title = {HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started},
journal = {International Journal of Immunogenetics},
year = {2021},
volume = {48},
number = {2},
pages = {193--200},
doi = {10.1111/iji.12517}
}
EUVIMED